In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Spiracur raises $35mm in third round

Executive Summary

In what appears to be its third round, Spiracur Inc. (developing a portable negative pressure wound therapy device) has raised $35mm. New investor Maverick Capital led (and takes a seat on the company's board) and was joined by Pinnacle Ventures and returning backers De Novo Ventures, Kleiner Perkins Caufield & Byers, and New Leaf Venture Partners. Spiracur's last-announced fundraising was a $20.3mm Series B round in July 2009.

Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies